T1	Treatment 110 122	chemotherapy
T2	Treatment 183 223	Human epidermal growth factor receptor 2
T3	Treatment 647 659	chemotherapy
T4	Treatment 859 876	anti-HER2 therapy
T5	Treatment 985 1076	local and central evaluation using immunohistochemistry combined with in situ-hybridization
T6	Treatment 1088 1204	evaluation of HER2 mRNA expression using kinetic RT-PCR from formalin-fixed, paraffin-embedded (FFPE) tissue samples
T7	Treatment 1818 1838	primary chemotherapy
